ACLS Flashcards

1
Q

vasopressin for cardiac arrest

A

40 units IV push in place of first or second dose of epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

adenosine for tachyarrhythmia in stable patient

A

6 mg rapid IV push

give in centrally located PIV line (e.g. antecubital)

can give 12 mg repeat doses x 2

be prepared for cardiac arrest

avoid in asthmatics

use only for regular, monomorphic tachyarrhythmias (paroxysmal SVT with/without aberrancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

diltiazem for tachyarrhythmia in stable patient

A

20 mg IV bolus over 2 min

repeat dose 25 mg x 1

use for PSVT (alternative/adjunct to adenosine) and for rate control in atrial tachyarrhythmias

avoid in pre-excitation syndromes (WPW)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

epinephrine infusion for symptomatic bradyarrhythmia

A

2 - 10 mcg/min

in patients failing atropine or with unstable rhythms (2° type II or 3° AV block)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

first three interventions (for nearly everything)

A

IV access

supplemental O2

set up Lifepak monitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

amiodarone for tachyarrhythmia in stable patient

A

150 mg IV bolus over 10 mins

repeat PRN

maintenance infusion of 1 mg/min for 6 hrs

use for wide-QRS tachyarrhythmias (stable VT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

procainamide for tachyarrhythmia in stable patient

A

20 - 50 mg/min IV gtt to maximum 17 mg/kg

maintenance infusion of 1 - 4 mg/min

monitor QRS duration (can be prolonged) and BP (can cause hypotension)

use for stable monomorphic VT

also use for tachyarrhythmias (e.g. afib/RVR) in patients with preexcitation (e.g. WPW)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

fluid bolus for BP support after ROSC

A

1 - 2 L IV bolus (NS or LR)

chilled to 4°C if hypothermia indicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

vagal maneuvers for tachyarrhythmia in stable patient

A

bear down: 10 sec straining, 5 sec relaxing x 3

use for regular, narrow-QRS tachyarrhythmias (e.g. paroxysmal SVT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CPR breaths with advanced airway in place

A

one breath q 6 - 8 seconds

(8 - 10 breaths/min)

do not interrupt chest compressions for breaths

avoid over-ventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

atropine for symptomatic bradyarrhythmia

A

0.5 mg IV bolus

repeat q 3 - 5 min up to 3 mg

ineffective in 2° type II and 3° AV block (acts at AV node) - skip directly to TCP or infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

parameters to monitor for CPR effectiveness

A

diastolic BP > 20 mm Hg

PETCO2 > 10 mm Hg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

metoprolol for tachyarrhythmia in stable patient

A

5 mg IV bolus

repeat q 2 - 5 min for 15 mg total

avoid in CHF or asthmatics

use for rate control of atrial tachyarrhythmias (afib, aflutter, EAT, MAT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

dopamine for BP support after ROSC

A

5 - 10 mcg/kg/min IV infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

epinephrine/norepinephrine for BP support after ROSC

A

0.1 - 0.5 mcg/kg/min IV infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

amiodarone for cardiac arrest

A

300 mg IV bolus (after first dose of epinephrine)

repeat dose 150 mg x 1

only for refractory VT/VF (give only for shockable rhythm)

15
Q

ROSC interventions

A

maintain SBP > 90 mm Hg (fluids, pressors)

maintain SpO2 > 94%

12-lead EKG

address treatable causes

induced hypothermia (32 - 34°C) if unresponsive

coronary reperfusion if indicated

16
Q

magnesium sulfate for torsades des pointes

A

2 g IV bolus in 10 mL D5W

maintenance infusion of 0.5 - 1 g/hr

use in addition to other indicated treatments for torsades des pointes (polymorphic VT)

17
Q

dopamine infusion for symptomatic bradyarrhythmia

A

2 - 10 mcg/kg/min

in patients failing atropine or with unstable rhythms (2° type II or 3° AV block)

19
Q

defibrillation for cardiac arrest

A

manufacturer recommended initial dose (150 - 200 J biphasic; 360 J monophasic)

escalate subsequent doses

shock only VT or VF

21
Q

transcutaneous pacing for symptomatic bradyarrhythmia

A

start at 60 bpm / 60 mA (can start 80/80)

increase current incrementally until capture

set current 5 - 10 mA above capture

consider analgesia before initiating

first-line for unstable rhythm (2° type II or 3° AV block) or in unstable patients

22
Q

general treatments for (suspected) ACS

A

aspirin 325 mg po chew

nitroglycerin (sublingual/spray)

supplemental O2 (4 L/min, titrate to SpO2 > 94%)

morphine IV

23
Q

5 H’s (reversible causes of cardiac arrest)

A

hypovolemia

hypoxia

hydrogen ion (acidosis)

hypo/hyperkalemia

hypothermia

(hypoglycemia)

24
Q

5 T’s (reversible causes of cardiac arrest)

A

tension pneumothorax

tamponade, cardiac

toxins

thrombosis, pulmonary

thrombosis, coronary

25
Q

synchronized cardioversion for unstable tachyarrhythmia

A

regular rhythm: 100 J

irregular rhythm: 200 J

wide-complex, irregular rhythm: unsynchronized defibrillation dose

26
Q

rescue breaths for patient with pulse

A

one breath q 5 - 6 seconds (10 - 12 breaths/min)

avoid over-ventilation

27
Q

epinephrine for cardiac arrest

A

1 mg IV push q 3 - 5 min (every other CPR cycle)

note: cardiac arrest (IV) formulation is 1:10,000; do not confuse with anaphylaxis (IM) formulation of 1:1,000